Who can administer
  
                  May be administered by registered competent doctor or nurse/midwife
      
  
        Important information
  
                  
- Restricted to micro/ID advice only (Red-light antimicrobial)
 
- If documented immediate, or severe delayed hypersensitivity reaction to penicillin: DO NOT GIVE THIS DRUG
 
- See under Dose for adjustments required in Renal impairment
 
      
  
        Available preparations
  
                  Zinforo 600mg vial
      
  
        Reconstitution
  
                  Water for injection
20ml per 600mg vial
Dilute further prior to administration
      
  
        Infusion fluids
  
                  Sodium chloride 0.9% or Glucose 5%
      
  
        Methods of intravenous administration
  
                  Intermittent intravenous infusion
- Add required dose to 100 to 250mL infusion fluid - choice of volume depends on clinical status of patient
 
- The total time between starting reconstitution of the drug and completing preparation of the intravenous infusion should not exceed 30 minutes
 
- Administer over 5 to 60 minutes (for twelve-hourly doses), or 120 minutes (for eight-hourly doses)
 
- Infusion related reactions can be managed by prolonging infusion duration
 
- A 50ml infusion may be used if required (eg fluid restriction) but the residual volume in the infusion line must be flushed through at the same rate to avoid significant underdosing
 
      
  
        Dose in adults
  
                  Standard dose
- Give 600mg every twelve hours
 
High dose
- Give 600mg every eight hours
 
Renal impairment
| Renal impairment | 
Standard dose | 
High dose | 
| eGFR 31 to 50 ml/minute | 
400 mg every 12 hours | 
400 mg every 8 hours | 
| eGFR 15 to 30 ml/minute | 
300 mg every 12 hours | 
300 mg every 8 hours | 
| End stage renal disease, including haemodialysis | 
200mg every 12 hours | 
200mg every 8 hours | 
Hepatic impairment
- No dosage adjustment required
 
      
  
        Storage
  
                  Store below 250C
      
  
        References
  
                  SPC January 2021
      
  
        Therapeutic classification
  
                  Cephalosporin antibiotic (5th generation)